Denali Therapeutics (DNLI) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 3, 2026, with voting open until June 2, 2026, at 11:59 PM ET.

• Shareholders can access proxy materials online or request paper/email copies by May 20, 2026.

• Meeting will be held virtually, allowing remote participation and voting.

Voting matters and shareholder proposals

• Election of three directors: Jennifer Cook, David Schenkein, M.D., and Ryan Watts, Ph.D.; board recommends voting for all nominees.

• Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Advisory vote on executive compensation, with board recommending approval.

Board of directors and corporate governance

• Board slate includes three nominees up for election at the annual meeting.